Brief: Paion Submits Marketing Authorization Application For Remimazolam

PAION AG

20/11/2019 14:26

Nov 20 (Reuters) - PAION AG  PA8G.DE :
    * ANNOUNCES SUBMISSION OF THE MARKETING AUTHORIZATION
APPLICATION
FOR REMIMAZOLAM IN PROCEDURAL SEDATION TO THE EUROPEAN MEDICINES
AGENCY
    * PLANS TO SUBMIT AN EXTENSION OF MARKETING AUTHORIZATION, A
SO-CALLED TYPE-II-VARIATION, FOR REMIMAZOLAM FOR GENERAL
ANESTHESIA IN EUROPE

Source text for Eikon:  ID:nEQ9Vwb4Va 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))